Cellyan Biotechnology Balance Sheet (2024-2025) | HKPD

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2024 Sep2024 Mar2025 Sep2025
Assets
Current Assets
Cash & Equivalents (Quarter) 0.62M0.36M0.75M0.19M
Short-term Investments (Quarter) 0.01M401.00400.00459.00
Cash & Current Investments (Quarter) 0.63M0.37M0.75M0.19M
Receivables - Net (Quarter) 3.70M4.88M4.66M5.09M
Receivables - Other (Quarter) 0.02M0.01M0.06M0.01M
Receivables (Quarter) 3.72M4.90M4.71M5.11M
Work In Process (Quarter) 0.33M
Inventory (Quarter) 0.93M0.56M
Current Deferred Tax Assets (Quarter) 1.26M2.16M
Prepaid Assets (Quarter) 1.26M0.90M0.45M0.68M
Current Assets (Quarter) 7.80M8.88M8.73M8.86M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 0.10M0.12M0.11M0.11M
Intangibles (Quarter) 0.03M0.09M0.10M0.09M
Goodwill & Intangibles (Quarter) 0.03M0.09M0.10M0.09M
Long-Term Deferred Tax (Quarter) 1.26M
Other Non-Current Assets (Quarter) 0.63M0.75M
Non-Current Assets (Quarter) 0.87M1.28M0.69M0.78M
Assets (Quarter) 8.67M10.16M9.42M9.63M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 1.42M1.82M
Notes Payables (Quarter) 0.03M
Payables (Quarter) 1.45M1.82M
Short term Debt (Quarter) 0.18M0.24M0.00M0.34M
Current Leases (Quarter) 0.63M0.49M0.45M
Current Taxes (Quarter) 0.22M0.12M0.11M0.12M
Current Deferred Revenue (Quarter) 0.19M-0.12M0.12M0.53M
Total Current Liabilities (Quarter) 3.18M3.60M2.92M3.03M
Non-Current Liabilities
Non-Current Debt (Quarter) 1.12M1.50M
Operating Leases (Quarter) 0.12M0.91M0.01M0.13M
Total Non-Current Liabilities (Quarter) 1.24M1.21M1.51M1.46M
Total Liabilities (Quarter) 4.41M4.81M4.43M4.49M
Shareholder's Equity
Total Debt (Quarter) 1.30M0.24M1.51M0.34M
Common Equity (Quarter) 4.25M4.99M
Shareholder's Equity (Quarter) 4.25M5.35M4.99M5.14M
Liabilities and Shareholders Equity (Quarter) 8.67M10.16M9.42M9.63M
Retained Earnings (Quarter) -0.00M2.36M1.50M1.66M